Form 4: IGM Biosciences Director Acquires Shares as Part of Compensation

Director Elizabeth H.Z. Thompson acquired 1,452 shares of IGM Biosciences common stock on March 29, 2024, as partial payment of a quarterly retainer.

Summary

• On March 29, 2024, Elizabeth H.Z. Thompson, a director of IGM Biosciences, Inc., acquired 1,452 shares of common stock.
• The acquisition was part of a partial payment of a quarterly retainer, according to the Issuer's Outside Director Compensation Policy.
• The shares were acquired at a price of $0.
• Following the transaction, Thompson directly owns 1,452 shares of IGM Biosciences common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. While a director buying shares can be seen as a positive signal, it's not necessarily indicative of significant positive news.

Positives

• A director's acquisition of shares can be seen as a positive signal, indicating confidence in the company's future.

Industry Context

Director share acquisitions are a common occurrence in publicly traded companies, often tied to compensation packages or personal investment decisions. This transaction is specific to IGM Biosciences and its director compensation policy.

Key Dates